ENDV (Endonovo Therapeutics) Days Payable: 0.00 (As of Jun. 2025)

What is Endonovo Therapeutics Days Payable?

Endonovo Therapeutics ENDV Days Payable is 0.00 as of Jun. 2025. The stock has 3 warning signs investors should review. Among 708 Biotechnology companies, Endonovo Therapeutics ranks worse than 141242.8% on this metric.

Endonovo Therapeutics's average Accounts Payable for the three months ended in Jun. 2025 was $3.36 Mil. Endonovo Therapeutics's Cost of Goods Sold for the three months ended in Jun. 2025 was $0.00 Mil.

The historical rank and industry rank for Endonovo Therapeutics's Days Payable or its related term are showing as below:

During the past 13 years, Endonovo Therapeutics's highest Days Payable was 117660.36. The lowest was 1483.55. And the median was 16534.50.

ENDV's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 113.56
* Ranked among companies with meaningful Days Payable only.

Endonovo Therapeutics's Days Payable declined from Jun. 2024 (51,510.63) to Jun. 2025 (0.00). It may suggest that Endonovo Therapeutics accelerated paying its suppliers.

Endonovo Therapeutics Days Payable Related Terms

Endonovo Therapeutics Days Payable Historical Data

* Premium members only.

The historical data trend for Endonovo Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Endonovo Therapeutics Days Payable Chart

Endonovo Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

3,594.70

16,534.50

28,141.50

44,872.19

117,660.36

Endonovo Therapeutics Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25
Days Payable	Get a 7-Day Free Trial															51,510.63	0.00	0.00	0.00	0.00

ENDV vs RGBP, IOBTQ, CNBX: Days Payable Comparison

For the Biotechnology subindustry, Endonovo Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Endonovo Therapeutics Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Endonovo Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Endonovo Therapeutics's Days Payable falls into.

Save Embed

Endonovo Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Endonovo Therapeutics's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (1.083	+	3.43)	/	2 )	/	0.007	*	365
=	2.2565					/	0.007	*	365
=	117,660.36

Endonovo Therapeutics's Days Payable for the quarter that ended in Jun. 2025 is calculated as:

	Days Payable (Q: Jun. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Mar. 2025 )	+	Accounts Payable (Q: Jun. 2025 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2025 )	*	Days in Period
=	( (3.359	+	3.358)	/	2 )	/	0	*	365 / 4
=	3.3585					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

Endonovo Therapeutics (ENDV) has a Days Payable of 0.00 as of Jun. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Endonovo Therapeutics and its competitors. Over the past decade, Endonovo Therapeutics' Days Payable has ranged from 1,483.55 to 117,660.36. According to the industry distribution chart, Endonovo Therapeutics ranks #999999 out of 708 companies in the Biotechnology industry.

Is Endonovo Therapeutics' Days Payable too high?

Endonovo Therapeutics' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 1,483.55 to a high of 117,660.36. Based on the distribution chart, Endonovo Therapeutics ranks #999999 out of 708 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.

How does Endonovo Therapeutics' Days Payable compare to RGBP and IOBTQ?

According to the Biotechnology industry distribution chart, Endonovo Therapeutics ranks #999999 out of 708 companies for Days Payable. This places Endonovo Therapeutics in the lower half of its industry. The industry median Days Payable is 113.56. Historically, Endonovo Therapeutics' own Days Payable has ranged from 1,483.55 to 117,660.36 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 113.56, based on 708 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Endonovo Therapeutics and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Endonovo Therapeutics's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Endonovo Therapeutics stock overvalued right now?

Endonovo Therapeutics (ENDV) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For Endonovo Therapeutics (ENDV), the current Days Payable is 0.00 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Endonovo Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies RGBP IOBTQ CNBX ADTX SCPX SIGY CARM CYTOF LIPO RMTG VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 6320 Canoga Avenue, 15th Floor, Woodland Hills, CA, USA, 91367

Website https://www.endonovo.com

Endonovo Therapeutics Inc develops, manufactures and distributes revolutionary medical devices that utilize Pulsed Electro Magnetic Field (PEMF) therapy that are focused on the rapid recovery of wounds and reduction of pain, edema and inflammation on and in the human body.